S&P 500   3,894.87 (-0.18%)
DOW   31,558.08 (+0.07%)
QQQ   321.56 (-0.63%)
AAPL   126.39 (-1.10%)
MSFT   235.00 (-0.82%)
FB   264.95 (+0.02%)
GOOGL   2,077.65 (+0.39%)
TSLA   706.13 (-1.71%)
AMZN   3,139.10 (-0.22%)
NVDA   545.61 (-1.46%)
BABA   238.25 (-1.42%)
CGC   35.72 (+2.85%)
GE   13.06 (-0.38%)
MU   92.34 (-2.55%)
NIO   44.17 (-11.23%)
AMD   85.79 (-0.69%)
T   28.35 (+0.93%)
F   12.53 (+4.59%)
ACB   11.43 (+3.53%)
DIS   194.94 (-0.02%)
BA   224.00 (-0.17%)
NFLX   551.71 (+0.19%)
BAC   35.63 (-0.45%)
S&P 500   3,894.87 (-0.18%)
DOW   31,558.08 (+0.07%)
QQQ   321.56 (-0.63%)
AAPL   126.39 (-1.10%)
MSFT   235.00 (-0.82%)
FB   264.95 (+0.02%)
GOOGL   2,077.65 (+0.39%)
TSLA   706.13 (-1.71%)
AMZN   3,139.10 (-0.22%)
NVDA   545.61 (-1.46%)
BABA   238.25 (-1.42%)
CGC   35.72 (+2.85%)
GE   13.06 (-0.38%)
MU   92.34 (-2.55%)
NIO   44.17 (-11.23%)
AMD   85.79 (-0.69%)
T   28.35 (+0.93%)
F   12.53 (+4.59%)
ACB   11.43 (+3.53%)
DIS   194.94 (-0.02%)
BA   224.00 (-0.17%)
NFLX   551.71 (+0.19%)
BAC   35.63 (-0.45%)
S&P 500   3,894.87 (-0.18%)
DOW   31,558.08 (+0.07%)
QQQ   321.56 (-0.63%)
AAPL   126.39 (-1.10%)
MSFT   235.00 (-0.82%)
FB   264.95 (+0.02%)
GOOGL   2,077.65 (+0.39%)
TSLA   706.13 (-1.71%)
AMZN   3,139.10 (-0.22%)
NVDA   545.61 (-1.46%)
BABA   238.25 (-1.42%)
CGC   35.72 (+2.85%)
GE   13.06 (-0.38%)
MU   92.34 (-2.55%)
NIO   44.17 (-11.23%)
AMD   85.79 (-0.69%)
T   28.35 (+0.93%)
F   12.53 (+4.59%)
ACB   11.43 (+3.53%)
DIS   194.94 (-0.02%)
BA   224.00 (-0.17%)
NFLX   551.71 (+0.19%)
BAC   35.63 (-0.45%)
S&P 500   3,894.87 (-0.18%)
DOW   31,558.08 (+0.07%)
QQQ   321.56 (-0.63%)
AAPL   126.39 (-1.10%)
MSFT   235.00 (-0.82%)
FB   264.95 (+0.02%)
GOOGL   2,077.65 (+0.39%)
TSLA   706.13 (-1.71%)
AMZN   3,139.10 (-0.22%)
NVDA   545.61 (-1.46%)
BABA   238.25 (-1.42%)
CGC   35.72 (+2.85%)
GE   13.06 (-0.38%)
MU   92.34 (-2.55%)
NIO   44.17 (-11.23%)
AMD   85.79 (-0.69%)
T   28.35 (+0.93%)
F   12.53 (+4.59%)
ACB   11.43 (+3.53%)
DIS   194.94 (-0.02%)
BA   224.00 (-0.17%)
NFLX   551.71 (+0.19%)
BAC   35.63 (-0.45%)
Log in
NASDAQ:TLMD

SOC Telemed Stock Forecast, Price & News

$7.95
-0.19 (-2.33 %)
(As of 03/2/2021 12:30 PM ET)
Add
Compare
Today's Range
$7.81
Now: $7.95▼
$8.09
50-Day Range
$6.81
MA: $7.78▼
$9.00
52-Week Range
$6.75
Now: $7.95▼
$12.08
Volume32,658 shs
Average Volume481,759 shs
Market Capitalization$712.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SOC Telemed, Inc. provides telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePsychiatry, and teleICU. The company was founded in 2004 and is based in Reston, Virginia.
SOC Telemed logo

Headlines

SOC Telemed- A Healthy Niche in Rural Hospitals
February 24, 2021 |  finance.yahoo.com
SOC Telemed, Inc. (NASDAQ:TLMD) Shares Could Be 41% Below Their Intrinsic Value Estimate
February 3, 2021 |  finance.yahoo.com
SOC Telemed Launches New telePulmonology Service Line
January 26, 2021 |  prnewswire.com
SOC Telemed Hires Top Executive Roles from Global Leaders in Healthcare and Tech
January 12, 2021 |  finance.yahoo.com
SOC Telemed builds up leadership team following public debut
December 16, 2020 |  bizjournals.com
SOC Telemed Expands Executive Leadership Team
December 14, 2020 |  finance.yahoo.com
SOC Telemed Inc. Cl A
December 4, 2020 |  wsj.com
SOC Telemed to Announce Third Quarter 2020 Financial Results and Host Conference Call
December 1, 2020 |  finance.yahoo.com
SOC Telemed Reports Third Quarter 2020 Results
December 1, 2020 |  finance.yahoo.com
SOC Telemed to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
December 1, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLMD
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.soctelemed.com
Phone703-678-2122
Employees287
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio0.24
Quick Ratio0.24

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash Flow$0.00 per share
Price / Cash Flow2,571.92
Book Value$0.61 per share
Price / Book13.03

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares89,624,000
Market Cap$712.51 million
Next Earnings Date3/8/2021 (Estimated)
OptionableOptionable

MarketRank™

Overall MarketRank™

1.67 out of 5 stars

Medical Sector

252nd out of 1,968 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

4th out of 25 stocks

Analyst Opinion: 3.4Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$7.95
-0.19 (-2.33 %)
(As of 03/2/2021 12:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLMD News and Ratings via Email

Sign-up to receive the latest news and ratings for TLMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SOC Telemed (NASDAQ:TLMD) Frequently Asked Questions

Is SOC Telemed a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SOC Telemed in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SOC Telemed stock.
View analyst ratings for SOC Telemed or view top-rated stocks.

What stocks does MarketBeat like better than SOC Telemed?

Wall Street analysts have given SOC Telemed a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SOC Telemed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting SOC Telemed?

SOC Telemed saw a decrease in short interest in the month of February. As of February 12th, there was short interest totaling 1,250,000 shares, a decrease of 32.4% from the January 28th total of 1,850,000 shares. Based on an average daily volume of 514,000 shares, the short-interest ratio is presently 2.4 days. Currently, 3.6% of the company's shares are sold short.
View SOC Telemed's Short Interest.

When is SOC Telemed's next earnings date?

SOC Telemed is scheduled to release its next quarterly earnings announcement on Monday, March 8th 2021.
View our earnings forecast for SOC Telemed.

What price target have analysts set for TLMD?

6 Wall Street analysts have issued 1-year price targets for SOC Telemed's stock. Their forecasts range from $10.00 to $12.00. On average, they anticipate SOC Telemed's share price to reach $11.40 in the next twelve months. This suggests a possible upside of 43.4% from the stock's current price.
View analysts' price targets for SOC Telemed or view top-rated stocks among Wall Street analysts.

Who are SOC Telemed's key executives?

SOC Telemed's management team includes the following people:
  • Mr. Hai V. Tran, Pres & COO (Age 51, Pay $514.69k)
  • Mr. Sean Banerjee, Chief Technology Officer (Age 52, Pay $344.65k)
  • Mr. John W. Kalix, CEO & Director (Age 47)
  • Mr. Christopher K. Knibb, Chief Financial Officer (Age 51)
  • Ms. Eunice J. Kim, Gen. Counsel & Corp. Sec. (Age 48)
  • Ms. Meg Hoyecki, VP of Marketing
  • Ms. Stephanie Tamburello Harris, Chief HR Officer
  • Dr. Alberto Peñalver, Chief of Psychiatry
  • Dr. William S. Krimsky, Chief of Critical Care
  • Dr. Andy Barbash, Chief of Neurology

Who are some of SOC Telemed's key competitors?

Some companies that are related to SOC Telemed include Tivity Health (TVTY), Ontrak (OTRK), Viemed Healthcare (VMD), HemaCare (HEMA), Baudax Bio (BXRX), GreenVision Acquisition (GRNV), Cryo-Cell International (CCEL), Emmaus Life Sciences (EMMA), Curative Biotechnology (CTYX), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHOD), BioRestorative Therapies (BRTXQ), BioRestorative Therapies (BRTX), Pacific Health Care Organization (PFHO) and American Caresource (GNOW).
View all of TLMD's competitors.

What is SOC Telemed's stock symbol?

SOC Telemed trades on the NASDAQ under the ticker symbol "TLMD."

Who are SOC Telemed's major shareholders?

SOC Telemed's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Warburg Pincus LLC (37.80%), Alyeska Investment Group L.P. (6.77%), Alyeska Investment Group L.P. (6.77%), BlackRock Inc. (2.93%), Bamco Inc. NY (1.95%) and Clearbridge Investments LLC (1.75%).

Which major investors are buying SOC Telemed stock?

TLMD stock was acquired by a variety of institutional investors in the last quarter, including Warburg Pincus LLC, Alyeska Investment Group L.P., Alyeska Investment Group L.P., BlackRock Inc., Bamco Inc. NY, Clearbridge Investments LLC, Magnetar Financial LLC, and Next Century Growth Investors LLC.

How do I buy shares of SOC Telemed?

Shares of TLMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SOC Telemed's stock price today?

One share of TLMD stock can currently be purchased for approximately $7.95.

How much money does SOC Telemed make?

SOC Telemed has a market capitalization of $712.51 million.

How many employees does SOC Telemed have?

SOC Telemed employs 287 workers across the globe.

What is SOC Telemed's official website?

The official website for SOC Telemed is www.soctelemed.com.

Where are SOC Telemed's headquarters?

SOC Telemed is headquartered at 1768 Business Center Drive Suite 100, Reston VA, 20190.

How can I contact SOC Telemed?

SOC Telemed's mailing address is 1768 Business Center Drive Suite 100, Reston VA, 20190. The company can be reached via phone at 703-678-2122.


This page was last updated on 3/2/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.